ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
Delayed Nasdaq  -  04:00 2022-08-15 pm EDT
18.32 USD   +4.87%
08/09ROCKET PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/09Raymond James Adjusts Rocket Pharmaceuticals' Price Target to $24 From $22, Maintains Outperform Rating
MT
08/08ROCKET PHARMACEUTICALS : Reports Second Quarter 2022 Financial Results and Highlights Recent Progress - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions